DROMDP: Dynamic ROM Via Gait Analysis and 3D Fluoroscopy in THA With Different Head Diameters

Sponsor
Istituto Ortopedico Rizzoli (Other)
Overall Status
Completed
CT.gov ID
NCT02047292
Collaborator
DePuy International (Industry)
30
1
3
47.6
0.6

Study Details

Study Description

Brief Summary

Pain and reduced function are the most common symptoms of coxarthritis. Pain relief and normal range of motion (ROM) restoration are the objectives of a Total Hip Arthroplasty (THA) procedure. It is recognized that increased head-neck ratio results in increased ROM due to the fact that prosthetic impingement between neck and acetabular liner occurs with wider arcs of motion. This head-neck ratio has been investigated extensively only in vitro (on cadavers or sawbones) or using mathematical modeling in computer simulations. These studies are limited by the lack of soft tissues and muscle activations in the models. This study will clinically assess the effect of prosthetic head diameter on patient capability of performing movements which require extreme arcs of motion of the hip joint. Therefore, the research questions are:

  • What role do soft tissues play in limiting ROM?

  • Can prosthetic impingement really occur in a well positioned THA?

  • Can a bigger head diameter alone reduce the risk of impingement?

Condition or Disease Intervention/Treatment Phase
  • Device: THA Corail PinnacleCoC28
  • Device: THA Corail DeltaMotion36
  • Device: THA Corail DeltaMotion40
N/A

Detailed Description

This will be a prospective comparative randomized double-blind Study (both patient and the clinical engineer performing the gait analysis will be blind with respect to the prosthetic head diameter implanted). Patient recruitment will last 12 months and the Study will have a follow-up period of 12 months. A total number of 45 patients will be recruited. Patients will be randomly allocated into three groups: the first group will undergo THA with a 28mm diameter head (Pinnacle Acetabular System, with a ceramic on ceramic - CoC - bearing), in the second group THA will be performed using a 36 mm diameter head (DeltaMotion), finally patients in the third group will undergo THA with a 40 mm diameter head (DeltaMotion). Patients will be operated by three surgeons of the same hospital according to the same surgical procedure and using the same direct lateral approach. All patients will receive a Corail stem and will follow the same rehabilitation program.

  • Primary endpoint: Gait analysis and fluoroscopy will provide quantitative information of prosthesis in vivo performance, e.g. what is the arc (degrees) of active or passive motion when prosthetic impingement occurs?

  • Secondary endpoint(s): these analyses will also allow to: 1) assess ROM of the operated hip versus contralateral non operated hip and the effect of prosthetic head diameter and any correlation to hip functional scores validated and commonly used in the Literature;

  1. set reproducible criteria for in vivo fluoroscopic analysis of ROM in THA patients.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Dynamic Range of Motion (ROM) Assessment Using Gait Analysis and Three-dimensional Fluoroscopy in Patients Treated by Total Hip Arthroplasty (THA) With Different Head Diameters
Study Start Date :
Jan 1, 2014
Actual Primary Completion Date :
Feb 1, 2016
Actual Study Completion Date :
Dec 21, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: THA28

THA Corail PinnacleCoC28

Device: THA Corail PinnacleCoC28
Uncemented THA with Corail stem and Pinnacle acetabular cup with CoC 28 mm head

Active Comparator: THA36

THA Corail DeltaMotion36

Device: THA Corail DeltaMotion36
Uncemented THA with Corail stem and DeltaMotion acetabular cup with 36 mm head

Active Comparator: THA40

THA Corail DeltaMotion40

Device: THA Corail DeltaMotion40
Uncemented THA with Corail stem and DeltaMotion acetabular cup with 40 mm head

Outcome Measures

Primary Outcome Measures

  1. Number of Participants and Hip Joint Positions with the Occurrence of Implant Impingement [12 months]

    Three-dimension videofluoroscopy is used to calculate prosthesis component relative pose, and to estimate minimum distance at the areas of risk of impingement

  2. Number of Participants with Functional Deficits at the Hip Joint as Measured by Gait Analysis [12 months]

    Three-dimension kinematics and kinetics of the trunk, pelvis and lower limb joints is used during level walking and other motor tasks, as well as for the single exercises of hip joint extreme motion analyzed in videofluoroscopy, to assess thoroughly those patients with and without impingement.

Secondary Outcome Measures

  1. Range of Motion of the operated hip versus contralateral non-operated hip [12 months]

    Standard clinical range of motion at the two hips

  2. Correlations between prosthetic head diameter and hip functional scores [12 months]

    The effect of prosthetic head diameter and any correlation to hip functional scores validated and commonly used in the Literature

  3. Standard Clinical Hip Scores [pre-op, and 12 months]

    Outcomes: Harris Hip Score, Oxford Hip Score, WOMAC, Forgotten Joint score and UCLA activity score will be assessed and recorded pre-operatively and post-operatively at one year after surgery.

  4. X-ray measurements [12 months]

    Radiographic assessment will also be performed at one year after surgery to assess implant position and osteointegration

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with unilateral primary or secondary hip arthrosis indicated for THA;

  • Men and female, age between 35 and 55 years old;

  • BMI smaller than 30;

  • Patients able to understand the protocol and to sign the informed consent.

Exclusion Criteria:
  • Child-bearing female;

  • Patients with also controlateral hip arthritis;

  • Neurological patients, because of possible alteration of neuro-muscular control of the replaced hip;

  • Patients treated with joint replacement at any other lower limb articulation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Istituto Ortopedico Rizzoli Bologna BO Italy 40136

Sponsors and Collaborators

  • Istituto Ortopedico Rizzoli
  • DePuy International

Investigators

  • Principal Investigator: Sandro Giannini, MD, Prof, Istituto Ortopedico Rizzoli

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Alberto Leardini, DPhil, Alberto Leardini, Istituto Ortopedico Rizzoli
ClinicalTrials.gov Identifier:
NCT02047292
Other Study ID Numbers:
  • IORDePuyD57613
First Posted:
Jan 28, 2014
Last Update Posted:
Feb 17, 2020
Last Verified:
Feb 1, 2020
Keywords provided by Alberto Leardini, DPhil, Alberto Leardini, Istituto Ortopedico Rizzoli
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 17, 2020